Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Bone and Joint Surgery. British Volume
|
August 28, 2004
Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome
S R Kearns, A F Daly, K Sheehan, et al.
Revue Medicale De Liege
|
April 8, 2017
[A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update]
H Valdes-Socin, L Palmeira, M-C Burlacu, et al.
Allergy
|
December 4, 2004
Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique
Y H Wang, Y Taché, A G Harris, et al.
Annales D'Endocrinologie
|
October 22, 2010
Familial pituitary adenomas
S Vandeva, V Vasilev, L Vroonen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 9, 2004
Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma
D Betea, A R Bradwell, T C Harvey, et al.
Journal of Endocrinological Investigation
|
December 4, 2009
Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features
F Magri, C Villa, D Locatelli, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 23, 2016
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency
F Castinetti, A F Daly, C A Stratakis, et al.
Endocrine
|
April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study
E C Coopmans, A Muhammad, A F Daly, et al.
European Journal of Endocrinology
|
January 20, 2017
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues
S E Franck, T I M Korevaar, P Petrossians, et al.
Clinical Genetics
|
May 29, 2010
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes
C A Stratakis, M A Tichomirowa, S Boikos, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Bone and Joint Surgery. British Volume
|
August 28, 2004
Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome
S R Kearns, A F Daly, K Sheehan, et al.
Revue Medicale De Liege
|
April 8, 2017
[A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update]
H Valdes-Socin, L Palmeira, M-C Burlacu, et al.
Allergy
|
December 4, 2004
Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique
Y H Wang, Y Taché, A G Harris, et al.
Annales D'Endocrinologie
|
October 22, 2010
Familial pituitary adenomas
S Vandeva, V Vasilev, L Vroonen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 9, 2004
Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma
D Betea, A R Bradwell, T C Harvey, et al.
Journal of Endocrinological Investigation
|
December 4, 2009
Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features
F Magri, C Villa, D Locatelli, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 23, 2016
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency
F Castinetti, A F Daly, C A Stratakis, et al.
Endocrine
|
April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study
E C Coopmans, A Muhammad, A F Daly, et al.
European Journal of Endocrinology
|
January 20, 2017
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues
S E Franck, T I M Korevaar, P Petrossians, et al.
Clinical Genetics
|
May 29, 2010
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes
C A Stratakis, M A Tichomirowa, S Boikos, et al.
Page
of 3